PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013 2014 2015 2016 2017
This ongoing cooperative agreement supports CARs PEPFAR Strategy Objective 2. The goal of the cooperative agreement with the Clinical and Laboratory Standards Institute (CLSI) is to strengthen the HIV/AIDS and related co-infection laboratory capacity and implement laboratory quality improvement strategies in Kazakhstan, Kyrgyzstan and Tajikistan. CLSI is an international standards-developing and educational organization whose which mission is to develop and promote the use of best practices in clinical and laboratory testing. CLSI will facilitate the development and implementation in CAR laboratories of effective quality management systems (QMS) a set of key quality elements that must be in place for laboratory operations to deliver consistent, high quality and cost-effective laboratory services.
The target populations are the Ministries of Health and other laboratorians in KZ, KG, and TJ.
With the requested additional funding this cooperative agreement will primarily target laboratory managers and quality officers in HIV/AIDS laboratories of the national and oblast levels in KZ and KG.
The project will provide short-term targeted TA to implement project activities so there is no need for the project to become more cost-efficient over the longer term.
CLSI mentors will continue working with laboratory quality officers and other designated individuals to identify gaps in current laboratory operations, and to assist in QMS implementation. QMS implementation will be monitored and evaluated based on the number of laboratories supported, number of mentor visits conducted and on review of documented progress on quality improvement projects in those laboratories.
This mechanism supports CARs PEPFAR Strategy Objective 2.This activity is linked to HLAB BCNs of: (1) ASCP/ IM #12026 and (2) Columbia/ IM #12872. Reliable diagnosis and effective treatment of HIV infection would be impossible without quality laboratory services. Currently, no Central Asian country has a strategic plan for improving laboratory quality, nor a functioning national body overseeing laboratory performance standards, nor any system for laboratory accreditation or licensure for specific levels of competence. There is no culture of service quality, or any conception that clinicians who collect samples, order tests, and receive results, are the laboratorys clients. This lack of quality management and accountability to other components of the public health system creates barriers for people at risk for HIV infection to get tested, to receive and understand the results, and to have confidence in the accuracy of the testing. It is also very detrimental to the success of ART programs.
Clinical and Laboratory Standards Institute (CLSI) is an international standards-developing and educational organization, which provides TA on standards and guidelines for laboratories to develop internal quality systems. CLSI provides on-going capacity building assistance to the Republican (and oblast level) AIDS Centers and Blood Centers laboratories in Kazakhstan, Kyrgyzstan and Tajikistan by developing and implementing quality management systems (QMS) as part of strengthening national laboratory services. CLSI will follow up on QMS workshops held in KZ and KG during FY10-FY11 for laboratory leaders from both the central and oblast levels. CLSI mentors work closely with local laboratory quality officers and other designated individuals to identify gaps and begin /continue QMS implementation. Ongoing support includes hands-on assistance as well as facilitation of self-assessments and quality improvement projects in order to give quality managers successful experiences and encourage them to expand their work. To facilitate QMS implementation, laboratories are provided with QMS-related guidelines and companion documents, including the "Key to Quality" reference checklists; additionally, CLSI also offers local institutions CLSI memberships providing full access to all CLSI documents. CLSI's TA on laboratory QMS are linked to other partners laboratory related activities. For example, Columbia Universitys capacity-building activities on CD4 and viral load testing will be reinforced by introduction of QMS essentials.
With the requested additional funding for ROP12, this cooperative agreement will primarily target laboratory managers and quality officers in HIV/AIDS laboratories in KZ and KG. CLSI mentors will continue working with laboratory quality officers and other designated individuals to identify gaps in current laboratory operations, and to assist in the QMS implementation in two additional oblast level HIV/AIDS labs (KZ) and a national level HIV/AIDS lab (KG). The QMS implementation will be evaluated based on the number of laboratories supported, number of mentor visits conducted and on the review of the documented progress on quality improvement projects in those laboratories.
